Home » Topics » BioWorld Science

BioWorld Science
RSS

HIV vaccine research at NIAID

Aug. 16, 1996

HIV integrase inhibitor effective, non-toxic in vitro

Aug. 16, 1996

Higher doses of GEM-91 administered in phase I/II trial

Aug. 16, 1996

Preclinical development of GEM-92 underway at Hybridon

Aug. 16, 1996

Bayer discloses HIV protease inhibitors

Aug. 16, 1996

HHV-8 implicated in KS development

Aug. 16, 1996

Lidak initiates further trials of Lidakol in oral herpes

Aug. 16, 1996

Hybridon prepares for GEM-132 clinical testing

Aug. 16, 1996

FDA approves generic clotrimazole

Aug. 16, 1996

Preclinical results presented for RCK-11

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...